US Edition
Bayer proposes US$10.25 billion plan for all Roundup cancer cases
Bayer aims to resolve about 65,000 current and future claims with a $7.25 billion fund, plus $3 billion for other cases, requiring court approval.
- On Tuesday, Bayer's Monsanto unit filed a proposed $7.25 billion nationwide class settlement in St. Louis Circuit Court to resolve current and future Non-Hodgkin lymphoma claims.
- The move follows the U.S. Supreme Court agreeing to hear Bayer's failure-to-warn appeal, with oral arguments set for April 27, as Bayer argues federal law preempts state failure-to-warn suits under EPA-approved labels.
- The deal creates a long-term claims program with capped annual payments over 17 to 21 years, distributing compensation via a tiered grid with average awards up to $165,000 and maximum awards of $198,000.
- Bayer postponed publication of its 2025 results and 2026 guidance to March 4 as it reflected the agreements, warning provisions will rise to 11.8 billion euros and shares jumped after the announcement.
- A favorable Supreme Court ruling could wipe out several large verdicts on appeal and sharply limit Bayer's liability, while approximately 65,000 plaintiffs still have pending claims after prior $10 billion payouts.
180 Articles
180 Articles
Monsanto, a subsidiary of the German agrochemical giant Bayer, announced on Tuesday in the United States an agreement of up to $7.25 billion to settle "current and future" complaints about Roundup, its glyphosate herbicide accused of being carcinogen. ...
MedPage Today
Bayer Agrees to $7.25B Proposed Settlement Over Thousands of Roundup Cancer Lawsuits
(MedPage Today) -- Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people that its popular weedkiller Roundup...
Yesterday cheering on the stock market - not 24 hours later disillusionment. After the billion-dollar glyphosate comparison, investors struggle with the question: Is this a liberation strike or just a respite for Bayer?
Bayer proposes $7.25B plan to settle Roundup cancer lawsuits
Bayer is proposing a $7.25 billion plan to settle thousands of lawsuits claiming its Roundup weedkiller caused cancer — a high-stakes effort to cap years of mounting legal exposure that will pressure the company’s finances in the near term."This is a choice for speed and containment over a protracted legal battle," CEO Bill Anderson said Tuesday, describing the agreement as a pivotal step toward limiting long-running litigation tied to the herbi…
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
